CFTR and cystic fibrosis: To our knowledge, this study presents the first attempt to model the multi-domain F508del CFTR protein in silico bound to a corrector compound and used methods compatible with computer-aided drug design in the Rosetta Software Suite, a first step towards rational drug design for CF treatment.